Analysis of an Antibody-Drug Conjugate on a Novel Benchtop MALDI-TOF/TOF Platform

Posters | 2025 | Bruker | ASMSInstrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, MALDI
Industries
Pharma & Biopharma
Manufacturer
Bruker
Downloadable PDF for viewing
 

Similar PDF

Routine analysis of drug to antibody ratio and drug distribution with maXis II
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
Agilent BioHPLC columns Characterization of Antibody-Drug Conjugate Critical Quality Attributes
2026|Agilent Technologies|Brochures and specificationsApplications
Glycosylated and Deglycosylated Subunit Analysis of Antibody Drug Conjugates
Agilent Biopharma Workflow Solutions
Agilent Biopharma Workflow Solutions
2016|Agilent Technologies|Brochures and specifications